featured
DNA Vaccine Encoding Prostatic Acid Phosphatase for Progressive Castration-Sensitive Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase II Trial of a DNA Vaccine Encoding Prostatic Acid Phosphatase (pTVG-HP [MVI-816]) in Patients With Progressive, Nonmetastatic, Castration-Sensitive Prostate Cancer
J. Clin. Oncol 2019 Oct 23;[EPub Ahead of Print], DG McNeel, JC Eickhoff, LE Johnson, AR Roth, TG Perk, L Fong, ES Antonarakis, E Wargowski, R Jeraj, G LiuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.